Metal‐Organic Framework PCN‐224 Combined Cobalt Oxide Nanoparticles for Hypoxia Relief and Synergistic Photodynamic/Chemodynamic Therapy
Chemistry – A European Journal · 2024
DOI: 10.1002/chem.202400319 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – A European Journal, 2024. Verfasst von Haoming Yuan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Provincial Key Laboratory of Detection Technology for Tumor Markers, School of Chemistry and Chemical Engineering, Linyi University, 276000,…. Hauptthemen laut MEDLINE: Cobalt, Photochemotherapy, Metal-Organic Frameworks, Oxides. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province, the Key R&D Projects of Linyi City.
Abstract (Originalsprache)
Photodynamic therapy (PDT) and chemodynamic therapy (CDT) are promising tumor treatments mediated by reactive oxygen species (ROS), which have the advantages of being minimally invasive. However, the hypoxia of tumor microenvironment and poor target ability often reduce the therapeutic effect. Here we propose a tumor targeted nanoplatform PCN‐224@Co 3 O 4 ‐HA for enhanced PDT and synergistic CDT, constructed by hyaluronate‐modified Co 3 O 4 nanoparticles decorated metal‐organic framework PCN‐224. Co 3 O 4 can catalyze the decomposition of highly expressed H 2 O 2 in tumor cells to produce oxygen and alleviate the problem of hypoxia. It can also produce hydroxyl radicals according to the Fenton‐like reaction for chemical dynamic therapy, significantly improving the therapeutic effect. The cell survival experiment showed that after in vitro treatment, 4T1 and MCF‐7 cancer cells died in a large area under the anaerobic state, while the survival ability of normal cell L02 was nearly unchanged. This result effectively indicated that PCN‐224@Co 3 O 4 ‐HA could effectively relieve tumor hypoxia and improve the effect of PDT and synergistic CDT. Cell uptake experiments showed that PCN‐224@Co 3 O 4 ‐HA had good targeting properties and could effectively aggregate in tumor cells. In vivo experiments on mice, PCN‐224@Co 3 O 4 ‐HA presented reliable biosafety performance, and can cooperate with PDT and CDT therapy to prevent the growth of tumor.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shandong Provincial Key Laboratory of Detection Technology for Tumor Markers, School of Chemistry and Chemical Engineering, Linyi University, 276000, Linyi, Shandong, P. R. China.
- Linyi Mental Health Center, 276000, Linyi, Shandong, P. R. China.
ORCID-Profile: Pengfei Shi
Förderung
- Natural Science Foundation of Shandong Province
- the Key R&D Projects of Linyi City
Zitieren
APA
Yuan, H., Chen, K., Geng, J., Wu, Z., Wang, C., & Shi, P. (2024). Metal‐Organic Framework PCN‐224 Combined Cobalt Oxide Nanoparticles for Hypoxia Relief and Synergistic Photodynamic/Chemodynamic Therapy. Chemistry – A European Journal. https://doi.org/10.1002/chem.202400319
Vancouver
Yuan H, Chen K, Geng J, Wu Z, Wang C, Shi P. Metal‐Organic Framework PCN‐224 Combined Cobalt Oxide Nanoparticles for Hypoxia Relief and Synergistic Photodynamic/Chemodynamic Therapy. Chemistry – A European Journal. 2024. doi:10.1002/chem.202400319
BibTeX
@article{Yuan2024,
author = {Yuan, Haoming and Chen, Kaixiu and Geng, Jing and Wu, Ziyong and Wang, Chao and Shi, Pengfei},
title = {Metal‐Organic Framework PCN‐224 Combined Cobalt Oxide Nanoparticles for Hypoxia Relief and Synergistic Photodynamic/Chemodynamic Therapy},
journal = {Chemistry – A European Journal},
year = {2024},
doi = {10.1002/chem.202400319}
}
EUVIMED